Introduction {#s1}
============

Accurate translation of mRNA into protein depends upon precise, repetitive three base translocation of the ribosome to maintain the correct reading frame throughout a coding sequence. Reading frame maintenance is challenging because multiple movements of the tRNAs and mRNA as well as conformational changes within the ribosome itself are required to complete a single elongation cycle ([@bib58]). For instance, the tRNA acceptor stems move within the large subunit during formation of the hybrid state, while the joining of EF-G-GTP (eEF2 in eukaryotes) results in additional movement of tRNA, and finally completion of translocation, driven by Pi release, requires additional movements ([@bib6]; [@bib13]; [@bib58]; [@bib62]; [@bib66]; [@bib67]; [@bib89]; [@bib99]). To accomplish this cycle, many interactions between the tRNAs and ribosome are disrupted, and new interactions are created, but the relative position of the tRNA anticodon to the mRNA codon must be maintained throughout all of these events ([@bib58]; [@bib19]; [@bib69]). Thus, it is critical that mechanisms exist to prevent slippage during these transitions.

Reading frame maintenance is facilitated by structures within the ribosome as well as by tRNA modifications. Structural features that contribute to reading frame maintenance, inferred from analysis of prokaryotic translation intermediates, include a swivel of the 30S head relative to the 30S body to form a contracted mRNA tunnel downstream of the A site prior to translocation ([@bib42]; [@bib72]). In addition, during translocation, two conserved bases in the 16S rRNA intercalate into different positions of the mRNA to prevent slippage ([@bib98]), while domain IV of EF-G contacts the codon and tRNA in the A/P site and h44 of 16S rRNA, likely coupling mRNA and tRNA movement ([@bib66]; [@bib99]). tRNA modifications within the anticodon loop also assist in reading frame maintenance, inferred both from genetic and structural analyses. Mutants that affect several such modifications in both bacteria and eukaryotes result in increased frameshifting ([@bib3]; [@bib40]; [@bib90]; [@bib92]; [@bib94]). Moreover, a cross-strand base stacking interaction between a modified ms^2^i^6^A37 in an *E. coli* tRNA^Phe^ and the mRNA codon is proposed to prevent slippage of P site tRNA on the mRNA ([@bib42]). Thus, a number of mechanisms exist to prevent loss of reading frame.

Nevertheless, ribosomes do move into alternative reading frames in response to specific sequences and structures in mRNA ([@bib3]; [@bib19]; [@bib20]). The existence of such events has implied that ribosomal plasticity with respect to reading frame movement is an integral function of the translation machinery. The common feature of all frameshifting events in bacteria to humans is that the ribosome stalls ([@bib19]). The stall can be mediated by combined effects of the A and P site codons ([@bib24]; [@bib26]), by the presence of downstream structures, or by an upstream Shine-Dalgarno sequence in bacteria ([@bib14]; [@bib20]). Analysis of programmed frameshifting indicates that additional sequences or protein factors are frequently required to mediate efficient frameshifting ([@bib3]; [@bib20]). For instance, +1 programmed frameshifting events are frequently enhanced by stimulatory sequences, although the role of these sequences is not always clear ([@bib30]; [@bib87]).

The identification of mutants that either affect programmed frameshifting or suppress frameshift mutations has pointed to four key factors in reading frame maintenance. First, mutations of ribosomal proteins, particularly those that contact the P site tRNA can cause increased frameshifting. In bacteria, frameshifting mutations are suppressed by deletions within the C terminal domain of ribosomal protein uS9, which contacts the P site tRNA anticodon loop ([@bib40]). In the yeast *Saccharomyces cerevisiae*, programmed frameshifting in the L-A virus is affected by mutations in 5S rRNA or its interactors uL18 or uL5, that also contact the P site tRNA ([@bib57]; [@bib68]; [@bib81]). Frameshifting mutations are also suppressed by a mutation in the yeast *RPS3*, although this mutation does not affect a tRNA contact ([@bib37]). Second, mutations in the basal translation machinery can also affect frameshifting. For instance, frameshifting mutations are suppressed by mutations in both EF-1α, which delivers tRNA to the ribosome ([@bib70]), and in *SUP35*, encoding the translation termination factor eRF3 ([@bib96]). Third, miRNAs can affect the efficiency of programmed frameshifting, for instance at *CCR5* in humans ([@bib8]). Fourth, mutations that affect proteins with previously unknown functions in translation can either alter programmed frameshifting or suppress frameshifting mutations. For instance, in yeast, frameshifting mutations are suppressed by mutations in *MBF1*, encoding Multi-protein Bridging Factor 1 ([@bib37]), or in *EBS1* ([@bib25]), while in the porcine virus PRRSV, the RNA binding protein nsp1β stimulates both −1 and −2 frameshifting events ([@bib53]). Thus, reading frame maintenance is modulated by ribosomal components, many of which contact the tRNAs, as well as by non-ribosomal proteins and miRNAs. However, the roles of many of these proteins are not understood.

We set out to work out the mechanisms that maintain reading frame when eukaryotic ribosomes encounter a stall, the common feature of all frameshifting events. In bacteria, ribosome stalls due to limited availability or functionality of tRNA seem to suffice to cause frameshifting ([@bib32]; [@bib73]). In wild type yeast, ribosomes stall at CGA codon repeats, which inhibit translation due to wobble decoding of CGA by its native tRNA^Arg(ICG)^ ([@bib50]; [@bib51]). Although frameshifting was detected at several underrepresented heptanucleotide sequences in yeast ([@bib74]), it was not detected at CGA codon repeats ([@bib97]). Instead, eukaryotes have evolved new pathways to regulate inefficient translation events, such as the Ribosome Quality Control (RQC) pathway, in which these stalled ribosomes undergo ubiquitination of ribosomal proteins, followed by dissociation of the subunits, and recruitment of the RQC Complex, which mediates CAT tailing and degradation of the nascent polypeptide ([@bib9]; [@bib12]; [@bib11]; [@bib18]; [@bib43]; [@bib47]; [@bib75]; [@bib76]; [@bib93]; [@bib95]; [@bib45]; [@bib56]; [@bib79]; [@bib80]; [@bib82]). The ribosomal protein Asc1/RACK1 mediates these events ([@bib11]; [@bib49]); in the absence of Asc1, ribosomes fail to engage the RQC ([@bib80]), and also undergo substantial frameshifting at CGA codon repeats ([@bib97]). However, Asc1 sits on the outside of the ribosome at the mRNA exit tunnel and likely functions as scaffold for recruitment of other proteins, such as the E3 ubiquitin ligase Hel2/mammalian ZNF598 and Slh1 ([@bib45]; [@bib56]; [@bib79]; [@bib80]; [@bib82]). Based on the location of Asc1 and the precedent that Asc1 recruits other proteins to abort translation, we considered it likely that Asc1 cooperates with additional proteins to mediate reading frame maintenance at CGA codon repeats and set out to find such factors.

Here, we provide evidence that the Multi-protein Bridging Factor 1 (Mbf1) and ribosomal proteins Rps3 and Asc1 (homolog of human Rack1) work together to prevent translational slippage at CGA codon repeats. Frameshifting results from inactivation of *MBF1*, or from mutations in amino acids in Rps3 located on an exposed surface of the protein near the mRNA entry site. Asc1 was previously known to mediate recruitment of the RQC, mRNA cleavage and mRNA decay at similar stall sites ([@bib39]; [@bib49]; [@bib51]; [@bib80]), as well as reading frame maintenance ([@bib97]). We provide evidence that Asc1 and Mbf1 cooperate to mediate reading frame maintenance at similar sites, acting on a common set of substrates, including the seven most slowly translated codon pairs in yeast ([@bib26]). We examined the precise frameshift at one of these inhibitory pairs, CGA-CGG, purifying the frameshifted polypeptide, followed by analysis with mass spectrometry. We found that frameshifting occurs in the +1 direction at the CGA codon and moreover, that frameshifting is modulated by the competition between the in-frame and +1 frame tRNAs.

Results {#s2}
=======

*MBF1* (Multi-protein Bridging Factor 1) prevents frameshifting at CGA codon repeats {#s2-1}
------------------------------------------------------------------------------------

We considered it likely that proteins other than Asc1 worked to prevent frameshifting at CGA codon repeats for two reasons. First, Asc1 binds on the outside of the ribosome, not in the decoding center ([@bib64]), and thus is not positioned in any obvious way to assist with reading frame maintenance. Second, Asc1 recruits other proteins, Hel2 and Slh1, to recruit the RQC ([@bib12]; [@bib43]; [@bib80]), and thus is likely to work with other proteins in reading frame maintenance. Thus, we set out to identify genes responsible for reading frame maintenance at CGA codon repeats.

To isolate mutants that frameshift due to translation of CGA codon repeats, we set up a selection in which a +1 frameshift (caused by 6 adjacent CGA codons) was required to express the *URA3* gene. The native *URA3* gene was placed in the +1 reading frame downstream of an N-terminal domain of *GLN4* encoding amino acids 1--99 (*GLN4*~(1-99)~), followed by 6 CGA codons and one additional nucleotide upstream of the *URA3* coding region ([Figure 1A](#fig1){ref-type="fig"}). This strain exhibits an Ura^-^ phenotype, due to the low levels of frameshifting in an otherwise wild-type background, allowing for an Ura^+^ selection to obtain mutants with increased frameshifting. As an independent secondary screen for frameshifting mutants due to CGA codon repeats, we integrated a modified version of the RNA-ID reporter with *GLN4*~(1-99)~ followed by 4 CGA codons and one additional nucleotide upstream of the *GFP* coding region into the *ADE2* locus ([@bib17]; [@bib97]). Thus, GFP expression was dependent upon frameshifting efficiency ([Figure 1A](#fig1){ref-type="fig"}). To avoid obtaining mutations in the *ASC1* gene, the selection strain also contained a second copy of the *ASC1* gene on a plasmid. ([Figure 1A](#fig1){ref-type="fig"}). We selected Ura^+^ mutants from 40 independent cultures each of *MAT**a*** and *MATα *parents and then analyzed three Ura^+^ mutants from each culture by flow cytometry to measure GFP and RFP expression. Most mutants (60% of *MATα* mutants and 80% of *MAT**a*** mutants) showed elevated expression of GFP, and we studied those that exhibited relatively high levels of frameshifting, \>30% of that in an *asc1*Δ mutant ([Figure 1B](#fig1){ref-type="fig"}). Most mutants (43 of 48 examined) were recessive and mapped to a single complementation group, based on growth of diploids on media lacking uracil ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}), although four dominant mutants were also identified.

![*MBF1* (Multi-protein Bridging Factor 1) prevents frameshifting at CGA codon repeats.\
(**A**) Schematic of selection for mutants that frameshift at CGA codon repeats. The indicated CGA codon repeats plus one extra nucleotide were inserted upstream of the *URA3* and *GFP* coding region (with an upstream HA tag shown in purple), resulting in an Ura^-^ GFP^-^ parent strain. Additional copies of the *ASC1* gene were introduced on a *LEU2* plasmid to avoid recessive mutations in the native *ASC1* gene. To obtain mutants with increased frameshifting efficiency, Ura^+^ mutants were selected and screened for increased GFP/RFP. (**B**) Expression of *GLN4*~(1-99)~-(CGA)~4~+1-GFP is increased in the *MATa* Ura^+^ mutants from this selection. Flow cytometry scatter plot showing GFP fluorescence versus RFP fluorescence for three mutants from this selection (P15: *mbf1-R89K*, light blue; P25: *mbf1*Δ*125--151*, black; P38: *mbf1-K64E*, dark blue), for the *asc1*Δ mutant (red) and for the wild-type parent strain (gray). (**C**) Expression of the non-native tRNA^Arg(UCG)\*^ suppressed the Ura^+^ phenotype of mutant P25 at 30°C. Serial dilutions of the indicated strains with empty vector or expressing the mutant tRNA^Arg(UCG)\*^ were grown on the indicated media. (**D**) Mutations in the *MBF1* mutants map in conserved amino acids in both the *MBF1*-specific domain and the Helix-Turn-Helix (HTH) domain of Mbf1 protein. Alignment of yeast Mbf1 amino acids 60--100 with other eukaryotic species is shown (full alignment see [Figure 1---figure supplement 3A](#fig1s3){ref-type="fig"}). GFP/RFP of frameshifted (CGA)~4~+1 reporter is shown for mutants obtained from *MATa* (circles) and *MATα* (triangles) strains, with the color of markers corresponding to the consensus level of this residue (Blue: 50--90%, Red: \>90%), however the conserved residue for R61 is N, and for S86 is Q, with all others identical to yeast.](elife-39637-fig1){#fig1}

To confirm that inhibitory decoding of CGA codon repeats is required for frameshifting in these mutants, we showed that introduction of an anticodon-mutated exact match tRNA^Arg(UCG)\*^ suppressed the Ura^+^ phenotype of one mutant ([Figure 1C](#fig1){ref-type="fig"}). We have shown previously that expression of this exact match tRNA^Arg(UCG)\*^ results in efficient decoding of CGA codons and suppresses their inhibitory effects on gene expression ([@bib50]). Thus, the Ura^+^, GFP^+^ phenotype of this mutant was due to frameshifting that occurs when the ribosome translates CGA codon repeats inefficiently.

We demonstrated that mutations in the yeast gene *MBF1,* Multi-protein Bridging Factor 1, were responsible for the defects in reading frame maintenance in recessive high GFP mutants. We identified the mutated gene by complementation of the Ura^+^ phenotype of the P25 recessive mutant with two plasmids from a library that contains 97.2% of the entire yeast genome ([Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}) ([@bib44]). The complementing plasmids share a single ORF, *MBF1*. We confirmed that mutations in the *MBF1* gene are responsible for frameshifting in three ways. First, a plasmid with only the *MBF1* gene complemented the frameshifting Ura^+^ phenotype of two mutants ([Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"}). Second, deletion of *MBF1* in the parent selection strain ([Figure 1A](#fig1){ref-type="fig"}) converted that strain from GFP^-^ to GFP^+^, similar to deletion of *ASC1* ([Figure 1---figure supplement 2B](#fig1s2){ref-type="fig"}). Third, 19/19 mutants tested contain mutations in the *MBF1* gene. Point mutations isolated in our selection are located at conserved residues near the junctions between two domains ([Figure 1D](#fig1){ref-type="fig"}).

*MBF1* is a highly conserved gene in eukaryotes and archaea, generally less than 160 amino acids with an N-terminal Mbf1-specific domain (that differs between archaea and eukaryotes) and a conserved cro-like helix-turn-helix (HTH) domain ([Figure 1D](#fig1){ref-type="fig"}, [Figure 1---figure supplement 3A](#fig1s3){ref-type="fig"}). Mbf1, which was initially identified as a transcription co-activator in *Bombyx mori* ([@bib52]; [@bib84]), has been implicated in a similar function in yeast, in this case, interacting with the Gcn4, transcription regulator of the general amino acid control pathway ([@bib85]). In testing sensitivity to 3-aminotriazole (3-AT) ([@bib38]; [@bib71]), a phenotype of *gcn4* mutants due to inability to induce expression of *HIS3*, we found that two frameshifting point mutants (*mbf1-K64E* and *mbf1-I85T*) exhibit no growth defect even on high concentrations of 3-AT ([Figure 1---figure supplement 3B](#fig1s3){ref-type="fig"}). Moreover, deletion of *GCN4* does not affect frameshifting at CGA codon repeats in an *asc1*Δ mutant ([@bib97]). Thus, it is unlikely that the defect in reading frame maintenance in our *mbf1* mutants is related to *GCN4*. However, Mbf1 has also been implicated in translation, based on isolation of mutations in yeast *MBF1* that suppress frameshifting mutations ([@bib37]), and the weak association of the archaeal homolog with ribosomes ([@bib10]), but there is no information on its molecular role in translation.

Ribosomal protein Rps3 also mediates reading frame maintenance at CGA codon repeats {#s2-2}
-----------------------------------------------------------------------------------

To identify the mutated gene(s) in our dominant mutants, we performed whole genome sequencing in two *MATα* mutants and found that each mutant contains a single amino acid change (*S104Y* and *G121D*) in *RPS3*. Similarly, the two dominant *MAT**a*** mutants also contain mutations in the *RPS3* gene (*L113F* and a duplication of N22 to A30). *RPS3* encodes a universally conserved ribosomal protein, a core component of the mRNA entry tunnel with a eukaryotic-specific C-terminal extension that interacts with Asc1 ([@bib64]). One known mutation in *RPS3* (*K108E*) affects reading frame maintenance ([@bib37]), while others affect different aspects of translation, from initiation to quality control ([@bib22]; [@bib29]; [@bib54]; [@bib86]). The three residues *S104*, *L113* and *G121* implicated in reading frame maintenance in our study, as well as *K108*, are all found in two α-helices near the mRNA entry tunnel of the ribosome; these residues reside on the surface of the ribosome and could interact with mRNA or proteins outside of the ribosome ([Figure 2A](#fig2){ref-type="fig"}). Moreover, the identity of all four of these residues is conserved in eukaryotes, but different in bacteria and archaea ([@bib29]).

![Ribosomal protein Rps3 mediates reading frame maintenance with Mbf1 at CGA codon repeats.\
(**A**) Left: Yeast ribosome from PDB: 3J78 ([@bib83]) (light blue: small subunit; yellow: large subunit) showing Asc1/RACK1 (dark blue) and Rps3 (pink). Right: Residues of Rps3 in which mutations cause frameshifting are marked- *S104* (yellow), *K108* (green), *L113* (black), *G121* (gray). (**B**) Analysis of effects of *RPS3-K108E, mbf1*Δ *and RPS3-K108E mbf1*Δ mutations on expression of GFP/RFP protein (fluorescence), mRNA and protein/mRNA from reporters containing four Arg codons (AGA versus CGA) in-frame and in the +1 frame. (**C**) Assay for epistatic relationship between *RPS3* mutations from this selection and the *mbf1*Δ mutation. (**D**) Overproduction of Mbf1 protein in indicated *RPS3* mutants significantly decreased expression of frameshifted Gln4~(1-99)~-GFP fusion protein (\*\*\*p \< 0.001) analyzed by flow cytometry.\
10.7554/eLife.39637.009Figure 2---source data 1.(Source data file for [Figure 2B--D](#fig2){ref-type="fig"}).](elife-39637-fig2){#fig2}

We initially examined the effect of the *RPS3-K108E* mutation on both frameshifting and in-frame expression downstream of CGA codon repeats, and found that this mutation allows frameshifting but does not affect in-frame expression. We chose the *K108E* mutation because it is known to have only minor effects on the polysome to monosome ratio ([@bib22]), consistent with few nonspecific effects on translation. We introduced modified RNA-ID reporters into *rps3*Δ::*ble^R^* strains in which the only source of *RPS3* is a plasmid-borne copy (either wild type or *K108E*). As described previously, since the expression of GFP and RFP is driven by the bi-directional *GAL1,10* promoter, we use the ratio of GFP/RFP to reduce noise and cell type specific differences in induction of this promoter ([@bib17]). Neither the *RPS3* mutant nor a *mbf1*Δ mutant had a substantial effect on GFP/RFP fluorescence (protein), mRNA or protein/mRNA of reporters with CGA or AGA codon repeats in-frame ([Figure 2B](#fig2){ref-type="fig"}). We did note relatively minor, but compensatory effects, of the mutants on both GFP and RFP mRNAs (a 15--30% reduction in *mbf1*Δ mutants and a similar increase in the *RPS3--K108E* mutant) ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). The *RPS3-K108E* and *mbf1*Δ mutants each caused substantially increased frameshifted GFP/RFP protein and protein/mRNA in the construct with four CGA codons, but had only small effects on GFP/RFP mRNA; no frameshifting was seen with four AGA codons ([Figure 2B](#fig2){ref-type="fig"}; [Supplementary file 1](#supp1){ref-type="supplementary-material"}).

If Mbf1 and Rps3 proteins function in independent pathways to prevent frameshifting, we expected that *RPS3-K108E mbf1*Δ double mutants would frameshift more efficiently than either single mutant. Instead, we found that the double mutant *RPS3-K108E mbf1*Δ exhibited only a slight increase in frameshifted GFP/RFP protein; this increase is likely due to a slight increase in GFP/RFP mRNA relative to either single mutant, resulting in nearly identical protein/mRNA from the *mbf1*Δ and *RPS3-K108E mbf1*Δ mutants ([Figure 2B](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}). We also examined effects of combining *MBF1* mutants with other *RPS3* mutants, *S104Y* and *G121D* from our selection, to determine epistasis. In these cases again, each single mutant exhibited frameshifting and the double mutants exhibited similar amounts of frameshifted GFP/RFP to that in the *mbf1*Δ strain, although even an additive effect would be easily detectable ([Figure 2C](#fig2){ref-type="fig"}). Thus, we think it is likely that Mbf1 and the two α-helices in the N-terminal Rps3 protein have related roles in reading frame maintenance.

If Mbf1 and these two α-helices in Rps3 mediate a common function, then frameshifting in either *RPS3-S104Y* or *G121D* mutants might be suppressed by overproduction of *MBF1*. We found that introduction of additional copies of the *MBF1* gene into either of these mutants resulted in reduced expression of frameshifted GFP ([Figure 2D](#fig2){ref-type="fig"}). Frameshifted GFP was reduced to 30% in the *S104Y* mutant and to 60% in the *G121D* mutant ([Figure 2D](#fig2){ref-type="fig"}). Similarly, growth on media lacking uracil was severely compromised in the *RPS3-S104Y* mutant when *MBF1* was expressed on a multi-copy plasmid, relative to an empty vector control ([Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}), although both strains grow equally well on SD-Leu media. These observations are consistent with the idea that Mbf1 and Rps3 play similar roles in reading frame maintenance and support the idea that these *RPS3* mutations reduce Mbf1 function.

Mbf1 and Asc1 play distinct, but related, roles at CGA codon repeats {#s2-3}
--------------------------------------------------------------------

Since Asc1 is also required for reading frame maintenance at CGA codon repeats ([@bib97]), we examined the relationship between *MBF1* and *ASC1* on both frameshifting and in-frame expression, comparing GFP/RFP in the single mutants to that in the *asc1*Δ *mbf1*Δ double mutant. Asc1 is known to affect expression (both in-frame and +1 frame) downstream of four CGA codons ([@bib51]; [@bib97]), but we previously noted that inhibitory effects of CGA codons are mediated by CGA codon pairs ([@bib26]; [@bib50]). Therefore, we compared the effects of these mutants on a set of reporters with three CGA-CGA (or AGA-AGA) codon pairs flanked by two non-Arg codons ([Figure 3A](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}, [Supplementary file 2](#supp2){ref-type="supplementary-material"}) to effects on a set with four adjacent CGA (or AGA) codons ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}). Neither the upstream gene nor the arrangement of CGA codons affected the results.

![Mbf1 and Asc1 play distinct, but related, roles at CGA codon pairs.\
(**A**) Analysis of effects of *asc1*Δ*, mbf1*Δ *and asc1*Δ *mbf1*Δ mutations on protein expression (fluorescence), mRNA levels and protein/mRNA of *GLN4*~(1-99)~-GFP reporters containing three CGA-CGA codon pairs in the 0, +1, and −1 reading frames. GFP/RFP values are reported in all cases. (**B**) Western analysis of Gln4~(1-99)~-GFP fusion protein in yeast strains from (**A**) indicates the expression of frameshifted Gln4~(1-99)~-GFP full-length protein in all three mutants. The protein was detected by anti-HA antibody recognizing the HA epitope between the codon insert and GFP. The GFP and RFP values were measured by flow cytometry while harvesting for cell lysis. (**C**) Overproduction of Mbf1 suppressed frameshifting at CGA-CGA codon pairs in the *asc1*Δ mutant, but did not affect the in-frame expression, based on GFP/RFP expression from the indicated reporters shown in (**A**). ns: p \> 0.05, \*\*\*p \< 0.001.\
10.7554/eLife.39637.013Figure 3---source data 1.Source data file for [Figure 3A and C](#fig3){ref-type="fig"}).](elife-39637-fig3){#fig3}

As expected based on a previous report ([@bib80]), deletion of *ASC1* resulted in increased protein and mRNA levels of reporters with in-frame CGA-CGA codon pairs. By contrast, deletion of *MBF1* did not affect protein or mRNA levels substantially ([Figure 3A](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1A and B](#fig3s1){ref-type="fig"}, [Supplementary file 2](#supp2){ref-type="supplementary-material"}). Thus, Asc1 clearly has a unique role in regulating mRNA and RQC recruitment at CGA codon pairs, but overall expression, measured as protein/mRNA, of all in-frame reporters is similar in the wild type, *asc1*Δ, *mbf1*Δ, and *asc1*Δ *mbf1*Δ double mutants ([Figure 3A](#fig3){ref-type="fig"}). For the in-frame reporters, the relationship between GFP/RFP fluorescence and mRNA is linear; none of these mutants affect RFP mRNA ([Figure 3---figure supplement 1C and D](#fig3s1){ref-type="fig"}). However, the increase in mRNA in an *asc1*Δ mutant does not explain the increase in frameshifted GFP/RFP protein in this mutant. That is, the 2.7-fold increase in GFP/RFP mRNA from the +1 reporter in an *asc1*Δ mutant (relative to the wild type) cannot account for the \>50 fold increase in frameshifted GFP/RFP fluorescence ([Figure 3A](#fig3){ref-type="fig"}). Thus, an *asc1*Δ mutant clearly exhibits a defect in reading frame maintenance.

If increased frameshifted protein/mRNA in an *asc1*Δ mutant is due to a failure of the Mbf1 pathway, then we expected that *asc1*Δ *mbf1*Δ double mutants would frameshift with similar efficiency to the *mbf1*Δ mutant. In fact, the level of frameshifted GFP/RFP protein per mRNA was very similar in the single *mbf1*Δ mutant to that in the double *asc1*Δ *mbf1*Δ mutant ([Figure 3A](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1D](#fig3s1){ref-type="fig"}, [Supplementary file 2](#supp2){ref-type="supplementary-material"}). These results are most consistent with a single pathway of reading frame maintenance, which Asc1 influences.

We confirmed that the +1 GFP signal detected in our mutants was due to frameshifting rather than another aberrant translation event by directly measuring both the size and amount of GFP fusion protein. The amount of full-length GFP protein in the Western blot corresponds to the GFP/RFP values obtained from flow analysis ([Figure 3B](#fig3){ref-type="fig"}) indicating that +1 GFP/RFP signal in our mutants is due to frameshifting.

If the defect in the *asc1*Δ mutant that results in frameshifting is due to a failure of the Mbf1 pathway, then overproduction of Mbf1 in the *asc1*Δ mutant might suppress frameshifting in this mutant. We found that expression of *MBF1* on a multi-copy plasmid did suppress frameshifting in the *asc1*Δ strain to 1/3 that seen with an empty vector, but did not affect in-frame expression ([Figure 3C](#fig3){ref-type="fig"}). The overproduction of Mbf1 was not complementing a reduced abundance of Mbf1 in this mutant. We did not detect a reduction in Mbf1-HA (which complements the *mbf1*Δ mutant) in the *asc1*Δ strain ([Figure 3---figure supplement 2A](#fig3s2){ref-type="fig"}), although *asc1* mutants generally exhibit a defect in expression of small proteins ([@bib88]). We also considered that *mbf1* mutants might require additional Asc1 protein, but additional copies of *ASC1* did not suppress frameshifting in an *mbf1*Δ mutant ([Figure 3---figure supplement 2B](#fig3s2){ref-type="fig"}). Thus, the frameshifted GFP/RFP fluorescence in the *asc1*Δ strain is likely a result of both an increase in mRNA and a defect in the Mbf1 pathway. We infer that Mbf1 and Asc1 contribute in distinct ways to the response to CGA codon pairs, but we do not know if Asc1 also has a direct role in the reading frame maintenance pathway.

Mbf1 and Asc1 work at a common subset of inhibitory codon pairs and at a single inhibitory codon pair in a context-dependent manner {#s2-4}
-----------------------------------------------------------------------------------------------------------------------------------

To address the mechanism of frameshifting and to understand the relationship between Asc1 and Mbf1, we set out to identify the protein and sequence requirements for efficient frameshifting. We began by examining frameshifting at 12 of 17 inhibitory codon pairs all of which cause reduced expression and many of which exhibit high ribosome occupancy, indicative of slow translation ([@bib26]), a common feature of many frameshifting sites.

We found that Mbf1 and Asc1 act on the same inhibitory codon pairs. Frameshifting occurs with high efficiency at three codon pairs (CGA-CGA, CGA-CGG, and CGA-CCG) in the *mbf1*Δ mutant ([Figure 4A](#fig4){ref-type="fig"}), the only three pairs at which Asc1 substantially modulates in--frame expression levels relative to synonymous optimal reporters ([Figure 4B](#fig4){ref-type="fig"}). As might be expected, frameshifted GFP/RFP for CGA-CCG and CGA-CGA is greater in the *asc1*Δ *mbf1*Δ mutant than in the *mbf1*Δ single mutant ([Figure 4A](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}, [Supplementary file 2](#supp2){ref-type="supplementary-material"}). Surprisingly, this is not true for the CGA-CGG construct at which frameshifting is remarkably high (\~76% based on data from [Figure 4---figure supplement 2C](#fig4s2){ref-type="fig"}). We address the source of this high frameshifting below and the lack of synergy in the Discussion.

![Mbf1 and Asc1 work at a common subset of inhibitory codon pairs and at a single inhibitory codon pair in a context-dependent manner.\
(**A**) Frameshifted GFP/RFP fluorescence was detected at three inhibitory codon pairs ([@bib26]) in the *mbf1*Δ mutant, and at seven codon pairs in the *asc1*Δ *mbf1*Δ double mutant. Frameshifting was assayed from reporters bearing 3 copies of the indicated inhibitory codon pair and a +1 nucleotide to place GFP in the +1 frame. (**B**) In-frame expression downstream of three inhibitory codon pairs (CGA-CGA; CGA-CCG; CGA-CGG) was improved by the deletion of *ASC1*. The GFP^FLOW^ ratio is the ratio of GFP/RFP from reporters with three copies of an inhibitory pair relative to GFP/RFP from synonymous reporters with three copies of the optimized pair. (**C**) Mutation of either *ASC1* or *MBF1* allowed frameshifting at no-go sequences in the GFP reporter, and mutation of both *ASC1* and *MBF1* resulted in significantly more frameshifted GFP/RFP. (**D**) Variation of the sequences surrounding a single CGA-CGG inhibitory codon pair indicated that the 3' nucleotide downstream of the pair was required for efficient frameshifting. Frameshifted GFP/RFP from *GLN4*~(1-99)~-insert-+1 GFP reporters with a single CGA-CGG inhibitory codon pair was analyzed in the four indicated strains. Variations in the sequences surrounding this pair are shown in red. The construct, IOO contains the inhibitory CGA-CGG pair in position 1(I) and synonymous optimal pairs (AGA-AGA) in the positions 2 and 3 (OO) sites. The original IOO construct was measured separately (hash marks) and also reported in [Figure 4---figure supplement 2B](#fig4s2){ref-type="fig"}. (**E**) Analysis of effects of *asc1*Δ*, mbf1*Δ *and asc1*Δ *mbf1*Δ mutations on expression of *GLN4*~(1-99)~-GFP reporters containing the native yeast *AYT1* sequence with a single CGA-CGG codon pair in 0 and +1 reading frames. This native yeast sequence provoked significant amount of frameshifting.\
10.7554/eLife.39637.019Figure 4---source data 1.Source data file for [Figure 4A--E](#fig4){ref-type="fig"}.](elife-39637-fig4){#fig4}

Lower levels of frameshifting were also detected at 4 additional pairs (CGA-AUA, CGA-CUG, CGA-GCG, and CUC-CCG) in the *asc1*Δ *mbf1*Δ mutant, but not in the *mbf1*Δ single mutant ([Figure 4A](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}). Analysis of these seven codon pairs indicates that frameshifting was detected at the seven most slowly translated codon pairs in the yeast genome \[based on analysis in ([@bib26])\] and at every inhibitory pair with CGA in the 5' position, consistent with slow decoding of CGA in the P site ([@bib91]).

To test the idea that Asc1 and Mbf1 prevent frameshifting at any slowly translated sequence, we measured frameshifting at a sequence which forms a secondary structure to slow down translation and induces no-go mRNA decay ([@bib21]; [@bib36]; [@bib60]). In accordance with this idea, frameshifted GFP/RFP protein from both +1 and −1 constructs was detectable in wild type, greater in each single mutant and even greater in the *asc1*Δ *mbf1*Δ mutant ([Figure 4C](#fig4){ref-type="fig"}). By contrast, these mutants did not affect frameshifting efficiency at the programmed frameshift site for *TY1* ([Figure 4---figure supplement 1C](#fig4s1){ref-type="fig"}) ([@bib7]). Thus, Mbf1 and Asc1 regulate reading frame maintenance at a translational pause (no-go site), but do not enhance frameshifting at site in which translational slippage is encoded.

To define the source of efficient frameshifting in the CGA-CGG reporter, which has 3 CGA-CGG pairs ([Figure 4A](#fig4){ref-type="fig"}), we initially determined that the first CGA-CGG codon pair was responsible for highly efficient frameshifting ([Figure 4---figure supplement 2A and B](#fig4s2){ref-type="fig"}). To define the sequence requirements for efficient frameshifting, we varied the sequences surrounding this single CGA-CGG pair and measured frameshifted GFP/RFP in the various mutants. Either of two changes to the sequence downstream of the CGA-CGG pair (one a point mutation and another a codon insertion) eliminated efficient frameshifting in all three mutant strains ([Figure 4D](#fig4){ref-type="fig"}). Furthermore, altering the two nucleotides downstream of the first codon pair in the three codon pair reporter reduced frameshifted GFP/RFP in all three mutants and also restored the synergistic dependence on *MBF1* and *ASC1* ([Figure 4---figure supplement 2C and D](#fig4s2){ref-type="fig"}). By contrast, none of three upstream changes (to the single CGA-CGG reporter) substantially reduced frameshifting ([Figure 4D](#fig4){ref-type="fig"}). Thus, the CGA-CGG-C 7-mer is required for efficient frameshifting.

To find out if frameshifting can occur at single CGA-CGG pairs in other sequence contexts, we tested sequences from seven yeast genes in our reporters, including six codons on either side of CGA-CGG pair. Frameshifted GFP/RFP was detected in *asc1*Δ *mbf1*Δ mutants in all cases ([Figure 4E](#fig4){ref-type="fig"}, [Figure 4---figure supplement 2E](#fig4s2){ref-type="fig"}). In particular, the two native sequences with CGA-CGG-C resulted in frameshifted GFP/RFP in the single mutants ([Figure 4E](#fig4){ref-type="fig"}, [Figure 4---figure supplement 2E](#fig4s2){ref-type="fig"}). Thus, CGA-CGG-C is likely a frameshifting sequence, and contexts that allow frameshifting have not been eliminated from native genes.

+1 frameshifting occurs with the CGA codon in the P site {#s2-5}
--------------------------------------------------------

To understand how frameshifting occurs, we wanted to define the direction and position of the actual frameshift. The high efficiency of frameshifting at the CGA-CGG-CAC sequence provided a useful tool to study frameshifting since there is only a short potential frameshifting sequence (a single inhibitory codon pair). We inserted this sequence with its neighboring codons from the RNA-ID reporter into a construct for purification of the frameshifted polypeptide ([Figure 5A](#fig5){ref-type="fig"}). The construct was designed such that the protein could be purified either with an upstream affinity tag (GST) to yield all polypeptides or with a downstream affinity tag (Strep II or the ZZ domain of IgG) to yield only frameshifted polypeptides. Treatment with LysC, which cleaves after lysine was expected to yield a 16 or 17 amino acid peptide for analysis by mass spectrometry, depending upon the mechanism of frameshifting.

![Frameshifting occurs in the +1 direction with the CGA codon in the P site and is modulated by tRNA competition at the A site.\
(**A**) Schematic of the purification construct for the frameshifted peptide. An eight amino acid sequence with a single CGA-CGG pair from the RNA-ID reporter was inserted between a GST tag and an out-of-frame StrepII tag. LysC treatment of purified frameshifted protein yields a 16 or 17 amino acid peptide. The red nucleotide indicates the extra nucleotide in the +1 frame construct. (**B**) Schematic of four possible frameshifting events at the inhibitory CGA-CGG codon pair, each of which can be distinguished by one or two amino acids in the resulting peptide. Ribosomes can frameshift either in the forward direction (+1) or in the reverse direction (−2) when the P site is occupied by either the CGA codon (first amino acid in the out-of-frame peptide shown in green) or the CGG codon (the first amino acid in the out-of-frame peptide shown in orange). (**C**) Purified protein products of both in-frame and +1 frame constructs were analyzed by SDS-PAGE, stained with Coomassie Blue. The frameshifted protein of +1 frame construct from Strep purification (in red box) was excised, cleaved with LysC and analyzed by Mass Spectrometry, resulting in identification of the peptide shown below the figure. This peptide corresponds to that expected of a +1 frameshift occurring when the CGA codon occupies the P site. (**D**) Overexpression of tRNA corresponding to +1 frame codon improved frameshifting efficiency, while overexpression of tRNA corresponding to the next in-frame codon significantly reduced frameshifting. ns: p \> 0.05, \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001.\
10.7554/eLife.39637.023Figure 5---source data 1.(Source data file for 5D).](elife-39637-fig5){#fig5}

If frameshifting occurred in the local region near the CGA-CGG codon pair, there are four possible events that could all give rise to +1 GFP signal. Ribosomes could frameshift in the +1 direction with either the CGA or the CGG in the P site, yielding the RGTT or the RRTT sequences shown in [Figure 5B](#fig5){ref-type="fig"}. Alternatively, ribosomes could undergo −2 frameshifting at either codon, yielding the peptides RDGTT or RRGTT ([Figure 5B](#fig5){ref-type="fig"}). In yeast, −2 frameshifting was observed upon expression of the mammalian antizyme ([@bib55]) and −2 frameshifting also occurs in PRRSV virus ([@bib23]). We purified the frameshifted protein, as well as an in-frame control protein with the sequence expected for a −2 frameshift at CGG ([Figure 5C](#fig5){ref-type="fig"}) and subjected them to mass spectrometry. The frameshifted protein yielded the peptide VTNLRGTTWSHPQFEK, the expected peptide from a +1 frameshift beginning with the CGA codon in the P site of the ribosome. Thus, we infer that frameshift occurs with CGA in the P site, yielding only one Arg amino acid on the nascent peptide, then switches to a glycine codon GGC.

To determine if aminoacyl tRNA amounts affect frameshifting, we compared the effects of additional copies of specific Arg and Gly tRNAs on frameshifting in the *asc1*Δ *mbf1*Δ double mutant. We found that introduction of additional copies of the gene encoding tRNA^Arg(CCG)^, which decoded the in-frame CGG codon, severely reduced frameshifting ([Figure 5D](#fig5){ref-type="fig"}), as expected if arg-tRNA^Arg(CCG)^ competes with gly-tRNA^Gly(GCC)^ for the A site. Similarly, we found that addition of extra copies of tRNA^Gly(GCC)^ which decodes +1 frame GGC codon significantly increased frameshifting in our original CGA-CGG-CAC context, as might be expect if the GGC codon is used ([Figure 5D](#fig5){ref-type="fig"}). Additional copies of tRNA^Arg(ICG)^, tRNA^Asp(GUC)^, tRNA^His(GUG)^, tRNA^Ser(AGA)^ had little or no effect, as expected since none of the codons decoded by these tRNAs should be occupying the A site during frameshifting. These results indicate that the frameshifting occurs within the single CGA-CGG-CAC sequence and is modulated by the concentration of aminoacyl tRNAs decoding the out-of-frame codon.

Discussion {#s3}
==========

We have uncovered a eukaryotic specific system that maintains the reading frame when ribosomes stall. Reading frame maintenance of stalled ribosomes is achieved in two ways: by direct inhibition of frameshifting; and by aborted translation coupled with mRNA decay. The system is composed of two proteins that lack bacterial homologs, the archaeal/eukaryotic Mbf1 protein and the eukaryotic ribosomal protein Asc1/RACK1, as well as one universally conserved ribosomal protein Rps3. Mutations in any of these proteins result in increased frameshifting at CGA codon repeats. Moreover, the Rps3 residues in which mutations affect reading frame maintenance are specifically conserved in eukaryotes (and differ in archaeal and bacterial Rps3), consistent with a eukaryotic-specific mechanism. We suggest that when ribosomes stall ([@bib79]), two distinct sets of events occur: Asc1 triggers a set of responses that result in aborted translation, recruitment of the RQC complex and mRNA decay ([@bib11]; [@bib18]; [@bib75]; [@bib79]; [@bib80]; [@bib93]); while Mbf1 and Rps3 cooperate at the stalled ribosomes to prevent frameshifting ([Figure 6A](#fig6){ref-type="fig"}). In the absence of Mbf1 and Asc1, ribosomes frameshift efficiently, even at a single CGA-CGG pair in some cases, including sequences found in the native yeast genome. Frameshifting on the CGA-CGG codon pair occurs in the +1 direction, with the CGA codon in the P site of the ribosome and is modulated by availability of in-frame and +1 frame A site tRNAs.

![Models for the interplay between the Mbf1/Rps3 and Asc1-mediated RQC pathways and for the role of Mbf1 in reading frame maintenance.\
(**A**) Model of the two pathways that maintain reading frames of stalled ribosomes at CGA codons. Mbf1 and Rps3 act on stalled ribosomes to prevent frameshifting while Asc1 causes removal of many of these ribosome from the translating pool and destroys the mRNA with the stall sequence. (**B**) Two models of roles of Mbf1 and Rps3 in reading frame maintenance. In model I, Mbf1 (two domains shown in red) interacts with mRNA, and is recruited through an interaction with Rps3 (blue) to the leading stalled ribosome (gray) to restrict mRNA movement. The interaction must be transient, with removal of Mbf1 when the ribosome translocates. In model II, Mbf1 is recruited to the colliding ribosomes (light blue) possibly by both Asc1 (yellow) and Rps3. We postulate that again an interaction with mRNA could buffer the effects of ribosome collision.](elife-39637-fig6){#fig6}

The coordinated activities of both the Asc1 and Mbf1/Rps3 pathways are likely important to maintain the reading frame, since the absence of either pathway results in increased frameshifting. We think both pathways are likely engaged by similar stalls, since we noted evidence that Asc1 regulates expression (either in-frame or out-of-frame) at every sequence at which Mbf1 acted. However, there may be differences in the extent to which each pathway contributes at particular stall sites. For instance, at sequences at which frameshifting occurs rapidly (i.e. CGA-CGG-C), Mbf1 may play the critical role; in the absence of Mbf1, ribosomes frameshift before they can be captured by the Asc1 pathway. Generally, some fraction of ribosomes are removed from the translating pool with concomitant mRNA decay, while ribosomes that remain stalled are kept in-frame by Mbf1/Rps3 ([Figure 6A](#fig6){ref-type="fig"}).

The Asc1-mediated events couple mRNA decay to abortive translation ([@bib80]), thus effectively reducing the number and duration of ribosome stalls. The integration of RNA decay with translation is extensive: cleavage of mRNA occurs upstream of many ribosome stalls including at CGA repeats ([@bib15]; [@bib21]; [@bib34]; [@bib50]; [@bib79]) and is modulated by Asc1 ([@bib39]; [@bib49]). mRNA decay is triggered by many problems in translation, such as nonsense mediated decay (NMD), no-go and NonStop decay \[See ([@bib77]; [@bib78]) and by slow translation ([@bib61]; [@bib65]). For reading frame maintenance, it seems likely that both reducing the number of stalled ribosomes (by aborting translation) and removing the mRNA are important. Deletion of *ASC1* in a *mbf1*Δ mutant results in an increase in frameshifted GFP/RFP protein that is directly proportional to the increase in mRNA. However, *asc1*Δ mutants exhibit a 50-fold increase in frameshifting relative to wild type cells with less than a 3-fold increase in mRNA levels. One likely explanation for frameshifting in the *asc1*Δ mutant is that Mbf1 becomes limiting due to an increase in the number of stalled ribosomes; this idea is strengthened by the observation that overproduction of Mbf1 suppressed frameshifting in the *asc1*Δ mutant. Alternatively, Asc1 might also play a direct role in the reading frame maintenance function. Asc1 interacts with the C terminal region of Rps3 and could affect the conformation of Rps3 or its interaction with Mbf1. Mbf1 was found in the vicinity of Asc1 ([@bib59]) lending credence to the idea that Asc1 could interact with Mbf1 (although such an interaction cannot be obligatory).

We think Rps3 and Mbf1 inhibit frameshifting in a coordinated manner, perhaps due to their interactions with mRNA or to Mbf1's interaction with the ribosome. The role of Rps3 in this process is likely to involve interactions with either the incoming mRNA or proteins external to the ribosome. The *RPS3* mutations that affect frameshifting map to residues (*S104*, *L113, G121*, *K108*) on two α-helices or their connecting loop right next to the entering mRNA. Although this section of Rps3 is involved in helicase activity and initiation selectivity ([@bib22]; [@bib86]), the residues mutated in frameshifting selections were not specifically those involved in these activities. Instead, these residues all sit on the solvent side of the ribosome and could form an interface interacting with mRNA or mRNA-bound proteins. The role of Mbf1 is likely mediated by interactions with either or both of the mRNA ([@bib5]; [@bib46]) and the ribosome ([@bib10]; [@bib59]). The apparent RNA binding domain maps to the less conserved N terminal domain ([@bib46]), while ribosome binding activity of the archaeal homolog of Mbf1 maps to its C-terminal HTH domain and the linker at the N terminus of this domain, which are both conserved with eukaryotes ([@bib10]); our frameshifting mutations cluster in the conserved linker region of Mbf1. Moreover, Mbf1 is sufficiently abundant with \~85,000 molecules per cell to participate in general translation cycles, although it is less abundant than core ribosomal proteins (\~200,000) ([@bib48]).

There are two reasonable models to account for the role of Mbf1 and Rps3 in reading frame maintenance ([Figure 6B](#fig6){ref-type="fig"}). The first model is that Mbf1 has a loose association with mRNA and is recruited to the leading stalled ribosome by an interaction with Rps3; the interactions with the ribosome and the mRNA at the stall site could restrict mRNA movement in the ribosome. Based on structures of prokaryotic ribosomes caught in translocation, mRNA flexibility may occur in ribosomes lacking an A site tRNA due to few contacts with the region of mRNA near the A site ([@bib98]), or due to a failure of two rRNA pawls that lock the mRNA in a translocating ribosome ([@bib98]), or due to defects in the interactions with elongation factor 2 ([@bib99]). In the absence of Mbf1, the ribosome stall might allow sufficient time for mRNA flexibility, resulting in frameshifting. The second model, which is based on the observation that ribosome collisions trigger no-go decay ([@bib79]), is that Mbf1 is recruited to colliding ribosomes to buffer the collision effects; in this case Asc1 and Rps3 might both participate in Mbf1 recruitment. Mbf1 could prevent ribosome collision-mediated movement of the leading ribosome on the mRNA.

Frameshifting occurs by a mechanism that involves the interplay between the two adjacent codons, in which I•A wobble interaction in the P site in conjunction with competition between tRNAs entering the A site results in the frameshift, consistent with a model proposed by Baranov *et al*. ([@bib4]). Two lines of evidence support this mechanism. First, we demonstrated that, in the *asc1*Δ *mbf1*Δ double mutant, ribosomes frameshift at a single CGA-CGG codon pair (in a particular context) when the CGA codon occupies the P site. We infer that CGA codon in the P site is generally important for frameshifting, because six of the seven codon pairs on which ribosomes frameshift are CGA-NNN and the three efficient pairs are CGA-CNN. The wobble interaction between the CGA codon and tRNA could weaken the interaction between mRNA and the ribosome, which in turn could slow down the elongation cycle. Second, we found that frameshifting is influenced by the abundance of the in-frame and out-of-frame tRNAs for next position, which implies that the frameshift occurs after translocation of the CGA from the A site to the P site. We speculate that the flexibility of the wobble base pair interaction between inosine and other nucleotides could actively facilitate the acceptance of out-of-frame A site tRNA. For instance, we consider that a rare instance in which the A base in CGA is bulged out might be stabilized by the very strong I•C interaction, increasing the time available to accept the out-of-frame tRNA.

The eukaryotic specific reading frame maintenance activity, involving Mbf1 and ribosomal proteins Rps3 and Asc1, is likely to be important for translation accuracy in the yeast genome. Mutations in either *RPS3* or *MBF1* suppressed frameshifting mutations in several native yeast genes ([@bib37]). Moreover, mutations in *MBF1* and *ASC1* resulted in detectable frameshifting in a set of native gene sequences with only a single inhibitory codon pair flanked by six adjacent codons on each side, although it is apparent that the frameshifting potential within a particular sequence is not simply due to the presence of a single inhibitory codon pair. These results confirmed that Mbf1 with Rps3 and Asc1 play a critical role in maintaining the reading frame during normal translation cycles. It is still unknown why this eukaryote-specific reading frame maintenance system evolved and why it is important to eukaryotes, but not bacteria.

Materials and methods {#s4}
=====================

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type         Designation                                                            Source or\     Identifiers                                                                                                    Additional\
                                                                                              reference                                                                                                                     information
  -------------------- ---------------------------------------------------------------------- -------------- -------------------------------------------------------------------------------------------------------------- --------------
  Gene\                *MBF1/*\                                                                              SGD:S000007253                                                                                                 
  (*Saccharomyces*\    *YOR298C-A*                                                                                                                                                                                          
  *cerevisiae*)                                                                                                                                                                                                             

  Gene\                *ASC1/*\                                                                              SGD:S000004722                                                                                                 
  (*S. cerevisiae*)    *YMR116C*                                                                                                                                                                                            

  Gene\                *RPS3/*\                                                                              SGD:S000005122                                                                                                 
  (*S. cerevisiae*)    *YNL178W*                                                                                                                                                                                            

  Strain, strain\      BY4741                                                                 Open\                                                                                                                         
  background\                                                                                 Biosystems                                                                                                                    
  (*S. cerevisiae,*\                                                                                                                                                                                                        
  *MAT**a***)                                                                                                                                                                                                               

  Strain, strain\      BY4742                                                                 Open\                                                                                                                         
  background\                                                                                 Biosystems                                                                                                                    
  (*S. cerevisiae,*\                                                                                                                                                                                                        
  *MATα*)                                                                                                                                                                                                                   

  Genetic\             See Supplementary table 1 in\                                          this paper                                                                                                                    
  reagent\             [Supplementary file 3](#supp3){ref-type="supplementary-material"}                                                                                                                                    
  (*S. cerevisiae*)                                                                                                                                                                                                         

  Antibody             anti-HA\                                                               Roche          3F10,\                                                                                                         1:3000\
                       High Affinity\                                                                        catalog\#\                                                                                                     dilution
                       (Rat\                                                                                 11867423001;\                                                                                                  
                       monoclonal)                                                                           RRID:[AB_1](https://scicrunch.org/resolver/AB_10094468)[0094468](https://scicrunch.org/resolver/AB_10094468)   

  Antibody             Goat anti-Rat\                                                         Jackson\       catalog\#\                                                                                                     1:5000\
                       IgG-HRP\                                                               Immuno\        112-035-003;\                                                                                                  dilution
                       conjugate                                                              Research       RRID:[AB_2338128](https://scicrunch.org/resolver/AB_2338128)                                                   

  Antibody             anti-G-6-PDH\                                                          Sigma          catalog\#\                                                                                                     1:5000\
                       (Rabbit\                                                                              A9521; RRID:\                                                                                                  dilution
                       monoclonal)                                                                           [AB_258454](https://scicrunch.org/resolver/AB_258454)                                                          

  Antibody             Goat anti-\                                                            Biorad         catalog\#\                                                                                                     1:10000\
                       Rabbit IgG-\                                                                          1706515;\                                                                                                      dilution
                       HRP\                                                                                  RRID:[AB_11125142](https://scicrunch.org/resolver/AB_11125142)                                                 
                       conjugate                                                                                                                                                                                            

  Recombinant\         See Supplementary table 2 in\                                          this paper                                                                                                                    
   DNA\                [Supplementary file 3](#supp3){ref-type="supplementary-material"}                                                                                                                                    
  reagent                                                                                                                                                                                                                   

  Sequence-\           See Supplementary table 3\                                             this paper                                                                                                                    
  based\               in [Supplementary file 3](#supp3){ref-type="supplementary-material"}                                                                                                                                 
  reagent                                                                                                                                                                                                                   

  Sequence\            Random\                                                                Invitrogen     catalog\#\                                                                                                     
  -based\              Primers                                                                               48190011                                                                                                       
  reagent                                                                                                                                                                                                                   

  Commercial\          T4 DNA\                                                                Novagen        catalog\#\                                                                                                     Used for\
  assay or kit         Polymerase,\                                                                          70099                                                                                                          ligation-\
                       LIC-qualified                                                                                                                                                                                        independent\
                                                                                                                                                                                                                            cloning

  Commercial\          Super\                                                                 Invitrogen     catalog\#\                                                                                                     
  assay or kit         Script II\                                                                            18064014                                                                                                       
                       Reverse\                                                                                                                                                                                             
                       Transcriptase                                                                                                                                                                                        

  Commercial\          RQ1 Rnase-\                                                            Promega        catalog\#\                                                                                                     
  assay or kit         Free Dnase                                                                            M6101                                                                                                          

  Commercial\          RiboMAX\                                                               Promega        catalog\# P1300                                                                                                
  assay or kit         Large Scale\                                                                                                                                                                                         
                       RNA\                                                                                                                                                                                                 
                       Production\                                                                                                                                                                                          
                       System-T7                                                                                                                                                                                            

  Commercial\          MicroSpin\                                                             GE             catalog\#\                                                                                                     
  assay or kit         G-25 columns                                                                          27-5325-01                                                                                                     

  Commercial\          Fast SYBR\                                                             Applied\       catalog\#\                                                                                                     
  assay or kit         Green Master\                                                          Biosystems     4385612                                                                                                        
                       Mix                                                                                                                                                                                                  

  Commercial\          Glutathione\                                                           GE             catalog\#\                                                                                                     
  assay or kit         sepharose-4B                                                                          17-0756-01                                                                                                     

  Commercial\          MagStrep\                                                              IBA            catalog\#\                                                                                                     
  assay or kit         'type3' XT\                                                                           2-4090-002                                                                                                     
                       beads                                                                                                                                                                                                

  Chemical\            5-FOA                                                                  USBiological   catalog\#\                                                                                                     
  compound,\                                                                                                 F5050                                                                                                          
  drug                                                                                                                                                                                                                      

  Chemical\            Complete mini\                                                         Roche          catalog\#\                                                                                                     
  compound,\           EDTA-free\                                                                            11836170001                                                                                                    
  drug                 protease\                                                                                                                                                                                            
                       inhibitor                                                                                                                                                                                            

  Chemical\            leupeptin                                                              Roche          catalog\#\                                                                                                     
  compound,\                                                                                                 11017128001                                                                                                    
  drug                                                                                                                                                                                                                      

  Chemical\            pepstatin                                                              Roche          catalog\#\                                                                                                     
  compound,\                                                                                                 11359053001                                                                                                    
  drug                                                                                                                                                                                                                      

  Chemical\            Glutathione                                                            Sigma          catalog\#\                                                                                                     
  compound,\                                                                                                 G4251                                                                                                          
  drug                                                                                                                                                                                                                      

  Chemical\            Biotin                                                                 IBA            catalog\#\                                                                                                     
  compound,\                                                                                                 2-1016-002                                                                                                     
  drug                                                                                                                                                                                                                      

  Software,\           MultAlin                                                               ([@bib16])     <http://multalin.toulouse.inra.fr/multalin/>                                                                   
  algorithm                                                                                                                                                                                                                 
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Strains, plasmids, and oligonucleotides {#s4-1}
---------------------------------------

Strains, plasmids, and oligonucleotides used in these studies are listed in [Supplementary file 3](#supp3){ref-type="supplementary-material"}, Tables 1-3. Parents for all yeast strains described in this study were either BY4741 (*MAT**a** his3*Δ1 *leu2*Δ0 *met15*Δ0 *ura3*Δ0) or BY4742 (*MATαhis3*Δ1 *leu2*Δ0 *lys2*Δ0 *ura3*Δ0) (Open Biosystems). The *GLN4*~(1-99)~-(CGA)~6~+1-*URA3* reporter used in the selection was constructed with PCR-amplified DNAs (using oligonucleotides OJYW085, 086, 041, 089, 095 and 099), assembled by Ligation Independent Cloning (LIC) methods ([@bib1]; [@bib2]) and then integrated into the *CAN1*/*YEL063C* locus on the chromosome V, selecting for canavanine-resistance; constructs were checked by sequencing of genomic PCR fragments. RNA-ID reporters were constructed as described previously and integrated at the *ADE2* locus, using selection with *MET15* marker in *MAT**a*** strains or *S.pombe HIS5* marker in *MATα* strains ([@bib17]; [@bib26]; [@bib97]).

Yeast strains bearing *MBF1* deletions were constructed by amplification of the *kan^R^* cassette in the yeast strain from the corresponding knockout strain in the systematic deletion collection (Open Biosystems) ([@bib28]). The *MAT**a*** yeast strain bearing a deletion of *RPS3* was constructed by amplification of *ble^R^* cassette ([@bib31]) (oligos OW443 and OW445) and integration of this DNA into a strain bearing an *URA3* \[*RPS3*\] covering plasmid (pEAW433). Yeast strains bearing deletions of *ASC1* marked with the *S. pombe HIS5* marker (AW768), which have been described previously ([@bib97]), were constructed and maintained in the presence of a plasmid born copy of *ASC1* on a 2µ, *URA3* plasmid. To obtain the *asc1*Δ strain from the selection parent strain, the *ASC1* gene was deleted by a *ble^R^* cassette obtained by PCR amplification with oligos OW125 and OW126.

Plasmids bearing the *MBF1* gene were constructed by amplification of chromosomal *MBF1* gene from −580 in 5' UTR to +300 in 3' UTR with oligos OJYW124 and OJYW125, followed by cloning into the 2µ, *LEU2* vector (pAVA0577) and into the *CEN*, *LEU2* vector (pAVA0581) to create pEJYW203 and pEJYW176 respectively. The chromosomal HA-tagged *MBF1* was constructed by PCR amplification of HA-*kan^R^* sequence from pYM45 (Euroscarf) ([@bib41]) with oligos OJYW130 and OJYW132, bearing homology to *MBF1*, followed by integration into the *MBF1* locus. This *MBF1-HA Kan^R^* cassette from −580 in 5'UTR to +300 in 3'UTR of *MBF1* (+1992 including *Kan^R^* sequences) was amplified from the chromosome with oligos OJYW157 and OJYW158, cloned into the XmaI and NheI sites in Bluescript as pEJYW279. The *mbf1* point mutations *K64E* and *I85T* were individually introduced into the plasmid pEJYW279 to make pEJYW302 and pEJYW307 respectively. The *mbf1-K64E* cassette was directly PCR-amplified from the mutant strain YJYW290-P38 with oligos OJYW157 and OJYW158 followed by digestion with XmaI and BamHI and integration into these two sites on pEJYW279. The *mbf1-I85T* mutation was introduced by PCR amplification from *MBF1-HA* cassette with OJYW170, which contains the mutation, and OJYW166, followed by integration into pEJYW279 between BamHI and AatII sites. Reconstructed *mbf1* point mutants were introduced into YJYW2566 (BY4741, *HIS3^+^*) with XmaI/NheI digested pEJYW302 and pEJYW307 selecting with *Kan^R^* marker. The plasmid template for in vitro transcription of GFP and RFP fragments (pEJYW407 and pEJYW409) was constructed by PCR-amplifying pEAW315 with oligos OJYW295/OJYW296 (for GFP) or OJYW297/OJYW299 (for RFP) followed by digestion with SphI and XmaI and integration into these two sites on pSP73 (Promega, cat.\# P2221). Plasmids expressing tRNAs were obtained from Phizicky and Grayhack lab stocks ([@bib33]; [@bib35]; [@bib50]).

Selection for frameshifting mutants and identification of mutations {#s4-2}
-------------------------------------------------------------------

Ura^+^ mutants were selected from 40 independent cultures of each *MAT**a*** and *MATα* parent strains (YJYW289, YJYW329), and then were analyzed by flow cytometry to measure GFP and RFP expression. Ura^+^ GFP^+^ mutants, indicative of increased frameshifting efficiency, were selected for further study, with an emphasis on mutants that exhibited higher levels of frameshifting, that is GFP/RFP \>4, (28% *MATα* and 66% *MAT**a*** mutants). Diploids between 12 *MAT**a*** mutant and 20 *MATα* mutants were created by mating in YPD for 2 hr at 25°C and selection on SD-Lys-Leu-His media for diploid cells, followed by streaking for single colonies. Then overnights of the resultant diploids and their haploid parents were spotted on SD-Leu and SD-Leu-Ura plates, which were grown at 30°C.

To identify the relevant mutation in YJYW290-P25, we obtained the Leu^-^ derivative of this mutant (YJYW315) by screening replica plated single colonies from an overnight in YPD on YPD and SD-Leu plates. The Ura^+^/FOA-sensitive phenotype of this mutant was complemented with a genomic tiled library ([@bib44]), selecting for FOA-resistant cells. First, 17 pools of DNA, each of which contained 96 plasmids ([@bib44]), were transformed individually with \>1000 colonies per plate. Transformants of each pool were then scraped and saved in 2 ml YPD +8% DMSO. These saves were plated based on their OD~600~ (2 × 10^7^ cells/OD~600~ x ml) to obtain approximately 5,000 cells on SD-Leu and 50,000 cells on SD-Leu +0.5 xFOA. For 16 of 17 pools, there were no colonies on the FOA plates, while transformants of pool 15 had 330 FOA-resistant colonies with 1404 colonies on SD--Leu plate, corresponding to FOA-resistance for 2.3% cells. The plasmids responsible for FOA-resistance was identified by complementing with plasmids from individual rows and columns in this pool as described above, followed by complementation with individual plasmids. Two plasmids from this pool conferred FOA-resistance and share a single gene, *MBF1*. The *MBF1* gene in 19 recessive mutants was amplified from their genomic DNA with oligos OJYW124 and OJYW125, followed by sequencing to confirm the mutated residues.

Whole genome sequencing on two dominant *MATα* mutants was performed to identify the mutated genes. For each strain,\~30 OD~600~ yeast cells were harvested and re-suspended in 1 ml prep buffer (2% Triton X-100, 1% SDS, 100 mM NaCl, 10 mM Tris-Cl pH 8.0, 1 mM EDTA) with \~1.5 g Zirconia/Silica beads (from BioSpec, catalog\# 11079105z) and 1 ml PCA pH 8.0. The suspension was then vortexed at top speed for 3 min and mixed with 1 ml TE pH 8.0, followed by centrifugation in prespun PLG tubes (from 5prime, catalog\# 2302830). Nucleic acids in the aqueous layer were ethanol precipitated with 5 ml 100% ethanol, followed by freezing on dry ice and centrifugation for 20 min at 4,000 rpm at 4°C. The pellet was re-suspended in 200 µl TE and incubated at room temperature for 1 hr with 0.2 µg/µl RNaseA to remove RNA contamination, followed by addition of 200 µl 1 M Tris-Cl pH 8.0, 2 µl of 5 mg/ml glycogen and 400 µl PCA, and centrifugation for 2 min at top speed at 4°C. The aqueous layer (\~360 µl) was precipitated with 720 µl 100% ethanol and frozen on dry ice for 15 min; resulting pellets were re-suspended in 100 µl TE pH 8.0 and 100 µl 1 M Tris-Cl pH 8.0, followed by precipitation again with 400 µl 100% ethanol. The DNA pellet was then washed with 500 µl 70% ethanol and finally re-suspended in 50 µl sterile ddH~2~O. Whole genome sequencing was performed by the UR Genomics Research Center resulting in *RPS3* mutations in these two *MATα* mutants. Mutations in two *MAT**a*** dominant mutants were then identified by amplification of *RPS3* cassette with oligos OJYW159 and OJYW210, followed by sequencing.

Analysis of yeast growth {#s4-3}
------------------------

Appropriate control strains (previously studied) and 2--4 independent isolates of each strain being tested were grown overnight at 30°C in media indicated, diluted to obtain OD~600~ of 0.5, then serially diluted 10-fold twice; 2 µl diluted cells were then spotted onto the indicated plates and grown at different temperatures for at least two days.

Flow cytometry {#s4-4}
--------------

To examine mutants in either *RPS3* or *ASC1*, reporters were introduced into sets of strains bearing an *URA3* covering plasmid with either *RPS3* or *ASC1*, depending upon the chromosomal deletion. All sets of strains in a given panel contained the same *URA3* plasmid. Prior to analysis of GFP expression, strains were streaked on FOA containing plates, then single colonies were grown for analysis by flow cytometry.

Yeast strains bearing the modified RNA-ID reporters were grown overnight at 30°C in YP media (for strains without plasmid) or appropriate synthetic drop-out media (for strains with plasmid) containing 2% raffinose + 2% galactose + 80 mg/L Ade. The cell culture was diluted in the morning such that to the culture had a final OD~600~ between 0.8--1.0. Analytical flow cytometry and downstream analysis were performed for four independent isolates of each strain (Outliers were rejected using a Q test with \>90% confidence level) as previously described ([@bib17]). Each flow experiment was also performed with proper controls including a GFP^-^, RFP^+^ strain. The GFP/RFP value from this control strain was subtracted from all tested strains on the same day to show signals above background (negative values are set to 0). P values were calculated using a one-tailed or two-tailed homoscedastic t test in Excel, as indicated in the source data for relevant figures.

Western blotting {#s4-5}
----------------

Western analysis of the GFP fusion proteins in the modified RNA-ID reporter and Mbf1 protein in yeast strains were performed with anti-HA antibody as described previously ([@bib27]).

RT-qPCR {#s4-6}
-------

mRNA measurements with reverse transcription (RT) reaction and quantitative PCR were performed as described previously ([@bib26]) with one significant difference. Quantification of mRNA was performed using in vitro transcribed GFP and RFP mRNA fragments, synthesized from linearized plasmid pEJYW407 and pEJYW409 using RiboMAX Large Scale RNA Production System-T7 (Promega, cat.\# P1300). The synthesis reaction was followed by DNase treatment to remove the DNA template and by elution through MicroSpin G-25 columns (GE, cat.\# 27-5325-01) to remove unincorporated nucleotides. The synthesized RNA sample was analyzed by ultraviolet light absorbance at 260 nm on a nanodrop to determine the concentration and by electrophoresis to assess integrity. Each qPCR plate contained 5-point 1:5 dilution standard curves for both GFP and RFP, which were optimized to ensure that all samples fall into the linear range of the curves. For each tested strain, three biological replicates were analyzed.

Purification of frameshifted peptide {#s4-7}
------------------------------------

To purify the frameshifted peptide from yeast, a *LEU2* plasmid containing either in-frame or +1 frame protein purification constructs were transformed into the *asc1*Δ *mbf1*Δ strain (YJYW378). Two independent transformants (FOA treated) of each construct were grown overnight in SD-Leu media and transferred into 80 ml S-Leu + 2% raffinose media in the morning. After reaching an OD~600~ of 0.8--1.2, expression of the GST-StrepII-ZZ construct was induced by addition of 40 ml 3xYP + 6% galactose and growth was continued for 10 hr. Cells were collected by centrifugation and cell pellets were quick frozen on dry ice. The cell pellets were re-suspended in 1 ml extraction buffer (50 mM Tris-Cl pH 7.5, 1 mM EDTA, 4 mM MgCl~2~, 5 mM DTT, 10% Glycerol, 1 M NaCl, 2.5 µg/ml leupeptin, 2.5 µg/ml pepstatin) and lysed with bead beating (10 repeats of 20 s beating followed by 1 min on ice), essentially as described previously ([@bib63]). The cell lysate was collected from the bead beating tubes by puncturing the bottom with a hot needle and blowing with low pressure air. Solid contents were removed by centrifugation before the remaining lysate was divided into half and purified on either GSH or Streptactin resin.

For GST purification: the cell lysate was first diluted with equal volume No Salt Wash Buffer (50 mM Tris-Cl pH 7.5, 4 mM MgCl~2~, 5 mM DTT, 10% Glycerol) to bring the salt to 0.5 M NaCl. GSH resin \[Glutathione sepharose-4B from GE, catalog\# 17-0756-01; pre-washed with Wash Buffer (No Salt Wash Buffer + 0.5 M NaCl)\] (50 µl/ ml of lysate) was added to the diluted cell lysate and the mixture was nutated for 3 hr at 4°C. The resin was separated from the liquid by centrifugation at low speed (\<3,000 rpm) and washed twice with 0.5 ml Wash Buffer followed by 20 min nutation. The bound protein products were then eluted by nutating for 40 min with 100 µl Elution Buffer (Wash buffer + 20 mM NaOH + 25 mM glutathione); the elution step was repeated to increase the yield.

For Strep purification: the cell lysate was diluted with 5x volumes No Salt Wash Buffer (100 mM Tris-Cl pH 7.5, 1 mM EDTA, 2.5 µg/ml leupeptin, 2.5 µg/ml pepstatin) to bring the salt to 150 mM NaCl. MagStrep 'type3' XT beads \[from IBA, cat\# 2-4090-002; pre-washed with Wash Buffer (No Salt Wash Buffer + 150 mM NaCl)\] were added to the diluted cell lysate (80 µl/ 3.3 ml diluted cell lysate). After nutating for 2 hr at 4°C, resins were separated from liquid using a magnetic separator, then the resin was washed with 1 ml Wash Buffer three times without additional incubation. The bound protein products were then eluted by adding 50 µl Elution Buffer (Wash buffer + 50 mM biotin) and nutating for 10 min, followed by separation using magnetic separator; the elution step was repeated to increase the yield.

Mass spectrometry {#s4-8}
-----------------

The elution samples from both GST and Strep purification were analyzed by SDS-PAGE, followed by staining with Coomassie Blue. The bands from Strep purification of both in-frame and +1 frame constructs were excised and analyzed on the Q Exactive Plus Mass Spectrometer in the Mass Spectrometry Resource Center of the University of Rochester Medical Center.
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###### Related to [Figure 2](#fig2){ref-type="fig"}.

Effects of *RPS3-K108E*, *mbf1*Δ and *RPS3-K108E mbf1*Δ mutants on GFP/RFP protein, mRNA and protein/mRNA from in-frame and frameshifted *RLuc*-Arg~4~-GFP/RFP.

10.7554/eLife.39637.026

###### Related to [Figure 3](#fig3){ref-type="fig"}.

Effects of *asc1*Δ, *mbf1*Δ and *asc1*Δ *mbf1*Δ mutations on GFP/RFP protein, mRNA and protein/mRNA from *GLN4*~(1-99)~-GFP reporters with three CGA-CGA codon pairs in the 0, +1, and −1 reading frames.

10.7554/eLife.39637.027

###### Related to Key Resources Table in Materials and methods Strains, plasmids and oligonucleotides used in these studies.

10.7554/eLife.39637.028
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All data generated or analyzed during this study are included in the manuscript and supporting files.
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Decision letter

Green

Rachel

Reviewing Editor

Johns Hopkins School of Medicine

United States

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Multi-protein Bridging Factor 1(Mbf1), Rps3 and Asc1 prevent stalled ribosomes from frameshifting\" for consideration by *eLife*. Your article has been reviewed by four peer reviewers and the evaluation has been overseen by a Reviewing Editor and James Manley as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

We have received the comments from four expert reviewers all of whom found the genetic screen and its follow-up to contain interesting new experiments focused on the activities of the ribosome in the face of elongation distress. These studies argue that a factor, Mb1, previously implicated in transcription and translation, and the ribosomal protein S3 play a critical role in preventing frameshifting at sites of stalling. In the absence of frameshifting, when severe stalling occurs, the ribosome-associated protein Asc1 triggers a diverse set of quality control events that have been studied in some substantial detail by the field. While all the reviewers felt that this study nicely leveraged genetics to reveal unanticipated players in the ribosome-centric event, all were somewhat concerned that the study did not go sufficiently beyond the reporter-based screen to reveal molecular insights into the roles of these factors on the ribosome. There was extensive use of reporters, with very similar disruptive features, to detail the subtleties in the response to pause sequences, for example. The figures detailing the di-codon pair experiments (Figure 4) and experiments focused on a natural context (Figure 5) provided little new information and potentially could be placed in a supplemental figure. The most critical set of experiments that brought all the ideas in the manuscript together was Figure 6, where depletion and over-expression of tRNAs and mass spec were used to determine that the frameshifting is triggered only when CGA is in the P site with its associated I:A wobble base pairing.

In addition to some concerns that molecular mechanism was lacking, the reviewers all had concerns about the relative lack of analysis and discussion of the role of mRNA decay in the events being studied. As you will read in the detailed comments, the reviewers felt it is critical to generate RNA quantitation data on both the GFP and RFP mRNAs, and then to present the data in terms of these measurements. It is clear that there are some substantial effects on mRNAs levels that result from the various genetic mutations, and it likely that these effects do not account for the observed increases in GFP only on the +1 constructs. To support the strength of this conclusion, the RNA levels should be quantitated both for the (CGA)4 constructs as well as the (CGA)4+1 constructs, as the RNA changes will likely be equivalent, and there will only be increases in GFP on the +1 constructs. While we are relatively confident that the conclusions will hold, given the extent to which translation and decay are coupled in these pathways, this analysis seems critical, and a careful discussion important for the reader.

In addition to this main criticism (related to measuring RNA levels carefully), there are some smaller points to be addressed in the reviewer comments. For example, the data and discussion on Hel2/Slh1 seemed over-interpreted or unclear. At a glance, there are no substantial differences that result when these factors are deleted. Moreover, the discussion of how these pathways might intersect or what these data might mean were not easy to follow. The manuscript would benefit from removal from the main text of figures that add little to our understanding of the role of these new factors (Mbf1 and S3) but simply support the results of the initial screen (yeast growth plates and the very detailed study in Figure 5, for example). What would benefit from more discussion is a more complete analysis about how these results fit in with the literature on mRNA decay, and most importantly, some thoughts about what Mbf1 might be doing. A model figure with the relative positions of S3 and Asc1 on the ribosome might help frame such a discussion, even in the absence of new biochemical information on Mbf1.

In light of the strength of the screen and the identification of an interesting new player in ribosome quality control, the reviewers support publication in *eLife* if the various concerns are all addressed.

While the study fails to provide substantive mechanistic insights, we feel that the screen and follow-up to confirm the role of Mbf1 in preventing frameshifting will be a valuable contribution to the field.

Thank you for submitting your excellent work to the journal.

*Reviewer \#1:*

In this paper, Wang and colleagues study protein factors and pathways that regulate translational frameshifting of stalled ribosomes. Previous work by the Grayhack lab identified Asc1 as a regulator of translational frameshifts for ribosomes decoding translation-inhibitory codons. Using a forward genetic screen in budding yeast, Wang and co-authors discover two more players in this process: Rps3 and Mbf1. The authors use genetic manipulations, translational reporters, and mass spectrometry to identify the contributions of different pathways to translational frameshifting and gain some mechanistic insight into how this process occurs.

The identification of the Mbf1/Rsp3 system of translational frame maintenance is an important contribution to the field and opens up new areas of research. Furthermore this work represents a systematic genetic dissection of the determinants of translational frameshifting, and the authors confirm the conclusions informed by synthetic stalling sequences using endogenous genomically-encoded sequences. However, additional and critical controls are necessary to support the authors\' conclusions. Specifically, this work relies heavily on a ratiometric, fluorescent reporter system based on a bidirectional pGAL1,10 promoter. In this reporter, two separate mRNAs are created, one to use as an expression control (RFP) and one as an experimental condition that encodes various test sequences upstream of a GFP in different frames. By comparing protein expression levels between the two messages, the authors hope to quantify the effect of the experimental conditions on translation. Yet this system also is sensitive to changes that affect mRNA levels of sequences that stall ribosomes. In fact, all the results reported in this study could be the result of how Asc1, Mbf1, and Rps3 affect decay of mRNAs that encode stalls and frameshifts. This is more than a hypothetical possibility, as *asc1∆* has been reported to affect mRNA levels of messages with stalls (Kuroha et al., 2010; Ikeuchi et al., 2016; Sitron et al., 2017).

The paper is fit for publication in *eLife* if the authors can address this major concern as detailed below.

1\) The pGAL1,10-RFP/insert-GFP reporter system needs additional validation to ensure that measurements of GFP/RFP values truly report on increases in the frequency of stall readthrough or frameshifting rather than mRNA metabolism. This validation is of particular concern due to the data presented in Figure 3D. We plotted the mRNA levels of the (CGA-CGA)3+1 reporter against the corresponding GFP/RFP fluorescence values and found there is an almost perfect linear relationship between the levels of GFP mRNA and GFP/RFP fluorescence in the wt, *asc1∆, mbf1∆*, and *asc1∆mbf1∆* strains. The slope we plotted is not 1, however, since we do not have the standard curves for these primer sets, we cannot know the absolute differences in mRNA, only the relative increase. Thus, the increase in GFP/RFP fluorescence in the mutant strains could be driven primarily by an increase in mRNA levels of the stalling transcript rather than increased frameshifting frequency.

To validate the reporters used in the context of frameshifting and stalling, the authors must measure GFP and RFP mRNA levels of (CGA-CGA)3, (CGA-CGA)3+1, (CGA-CGA)3-1 reporters using absolute quantification (not relative quantification) in wt, *asc1∆, mbf1∆*, and *asc1∆mbf1∆* strains by RT-qPCR.

\- Include a standard curve for each primer set (varying cDNA input) to map experimental conditions back to absolute input levels. Ensure the assay is conducted in the linear range of the qPCR.

\- Include a plot of absolute levels of GFP mRNA vs RFP mRNA in each genetic condition to ensure that the mutations don\'t differentially affect the RFP and GFP-containing transcripts.

\- Plot absolute GFP/RFP mRNA vs GFP/RFP fluorescence for each reporter and genetic background mentioned above to ensure that mRNA levels alone do not account for apparent changes in GFP/RFP fluorescence ratios.

Absolute quantification is described in this link: https://www.thermofisher.com/us/en/home/life-science/pcr/real-time-pcr/real-time-pcr-learning-center/real-time-pcr-basics/absolute-vs-relative-quantification-real-time-pcr.html)

*Reviewer \#2:*

In prior work, Grayhack and colleagues identified pairs of adjacent codons that cause ribosome stalling. In the current work, they conduct an unbiased genetic screen and show that mutations in the ribosomal proteins Asc1 and Rps3, and in the protein Mbf1, promote frameshifting on these inhibitory codon pairs. Whereas Rps3 and Mbf1 appear to cooperate in maintaining reading frame, because double mutants do not enhance the phenotype of single mutants, Asc1 appears to promote frameshifting by limiting ribosome quality control pathways that turnover the stalled ribosomes (the *asc1* mutation also enhances readthrough of an in-frame reporter containing an inhibitory codon pair). Additional studies demonstrate that the nucleotides flanking the codon pairs can impact their ability to promote frameshifting. Finally, purification of the frameshifted proteins enabled the authors to show that mutation of these factors results in a +1 frameshift with the first of the codon of the bad codon pair in the P site.

While all three of these proteins were previously implicated in frameshifting by other groups (primarily Mike Culbertson), this work is independent of the previous work significantly expands the analysis to provide greater insight into the nature of the frameshift and the complementary versus independent roles of Rps3, Mbf1 and Asc1.

The function of Mbf1 is unclear. This protein has been implicated in both transcription and translation. As the assay for frameshifting involves a dual GFP-RFP reporter in which GFP and RFP are transcribed from the divergent GAL1,10 promoter, an important control is to examine RFP and GFP mRNA levels in the WT and mutant strains. While perhaps it is unlikely that the *mbf1* mutant would differentially affect transcription of the GFP and RFP reporters, analysis of these mRNA levels for the in-frame and +1 frameshift reporters would more definitively rule out this possibility.

*Reviewer \#3:*

The paper by Wang et al., identified a eukaryotic-specific mechanism to prevent frameshifting by stalled ribosomes. Previous work from the Grayhack group, through the use of genetic screens, identified a role for the ribosome-associated factor Asc1/Rack1 in maintaining frame during stalling events. Here, the authors elaborate on these screens and identified the multi-bridging factor 1 (Mbf1) as an additional important player in preventing frameshifting on inhibitory codons. Additional regions on ribosomal protein Rps3 were also identified as potentially functionally important in mediating Mbf1\'s function. In particular, mutations of residues on the solvent phase of the protein\'s mRNA entry tunnel region promote frameshifting, but do not increase it in an *mbf1* background. Furthermore, the effect of these mutations is suppressed by overexpression of Mbf1. In contrast, overexpression of Mbf1 did not rescue the effect of *asc1* deletion on frameshifting. This, together with the observation that *mbf1* deletion does not promote readthrough of inhibitory codon (unlike *asc1* deletion), suggest that the Mbf1 and Asc1 work independently of each other. The authors put forward a model explaining these results: Mbf1, in combination with Rps3, prevents frameshifting by stalled ribosomes, whereas Asc1 is responsible for recruiting downstream factors to dissociate the ribosome and degrade the nascent proteins.

Overall, this is a very thorough investigation of frame maintenance during stalling and the requirement of different factors to prevent frameshifting. While many studies have looked at the effects of stalling from an mRNA- and a protein-quality-control perspective, only a few have explored its effect on ribosome function. The study offers new insights into how different factors communicate with the ribosome to trigger multiple pathways to prevent frameshifting and initiate ribosome rescue.

1\) The paper would benefit from a model that could explain Mbf1\'s function. Do the authors propose a model whereby Mbf1 binding to the mRNA prevent it from slippage? Or is it its ribosome binding that prevent the ribosome from frameshifting? I understand testing either model is beyond the scope of the current paper, but it would be nice to see how the authors are thinking about the mechanism of Mbf1.

2\) Although unnecessary, it would be nice if the authors analyzed the ribosome profiling data of the Gilbert group on *asc1* deletion to see if frameshifting occurs on the native targets that are mentioned in Figure 5---figure supplement 1B.

*Reviewer \#4:*

In this manuscript the authors present the results of a screen (for growth on -Ura) conducted to look for mutants that confer an increase in +1 frameshifting when ribosomes are confronted with problematic CGA rich sequences within an ORF. Importantly, the screen was conducted in a background carrying two copies of Asc1 to avoid its (re)isolation as an interesting mutant. The screen yielded recessive mutations in Mbf1 and dominant mutations in the r-protein S3. The authors then proceeded to characterize in detail the frameshifting and readthrough properties of the various mutants, whether they act independently or synergistically, in the original growth assay as well as a great number of GFP reporter assays. The authors also include in this analysis deletions of Asc1, an r-protein previously implicated in readthrough and frameshifting on CGA-enriched sequences, and in ribosome quality control events. Based on the results in the manuscript, there is little doubt that Mbf1 and S3 play important roles in the events that take place on ribosome stalling at problematic CGA rich sequences. Disappointingly, this manuscript does not give much sense of what these factors might do at a molecular level as essentially the only experiment presented is a broad set of in vivo reporter assays that provide modest mechanistic insight. Also, importantly, given the well known connection between translational stalling and mRNA degradation, in particular as already detailed for Asc1, it seems essential that the authors take some effort to reconcile these diverse effects (while they do present data in Figure 3D, they don\'t acknowledge that there are substantial mRNA level effects that could explain a fraction of their +1 FS data). It is critical that this point be addressed. Overall, this manuscript extends the set of molecular players involved in specifying ribosome function at problematic mRNA sequences and provides a strong foundation for subsequent molecular characterization.

Specific points:

Not clear it is necessary to show plates and GFP reporter data in parallel throughout; results are simplest to digest in bar graphs from reporters (especially if both results are effectively the same).

Figure 3C -- discussion of results with Hel2/Slh1 was confusing -- my look at the data says there is nothing interesting going on with these double mutants (even if the asterisks say otherwise).

Figure 3D -- mRNA levels clearly do vary -- these values should be rigorously determined for CGA-4 and CGA-4-+1 reporters -- the expectation is that mRNA level changes in various genetic backgrounds will be similar, but that protein output will be quite distinct -- these data should be presented in a scatter plot that allows correlations in mRNA and protein levels to be directly compared.

Figure 4 -- revisiting of di-codon pairs does not add much to what the authors learn in this study -- the same pairs that were problematic in Cell paper appear to be problematic still, and are where the +1 FS signal is seen -- supplemental?

Figure 5 -- huge amount of work to define some vague contextual contributions to the +1FS phenomenon -- doesn\'t add much in terms of mechanism or even the rules for context -- supplemental?

Figure 6 -- very nice set of data identifying CGA in P site as the critical feature for permitting the +1 FS (or stabilization of mRNA).

10.7554/eLife.39637.031

Author response

> We have received the comments from four expert reviewers all of whom found the genetic screen and its follow-up to contain interesting new experiments focused on the activities of the ribosome in the face of elongation distress. These studies argue that a factor, Mb1, previously implicated in transcription and translation, and the ribosomal protein S3 play a critical role in preventing frameshifting at sites of stalling. In the absence of frameshifting, when severe stalling occurs, the ribosome-associated protein Asc1 triggers a diverse set of quality control events that have been studied in some substantial detail by the field. While all the reviewers felt that this study nicely leveraged genetics to reveal unanticipated players in the ribosome-centric event, all were somewhat concerned that the study did not go sufficiently beyond the reporter-based screen to reveal molecular insights into the roles of these factors on the ribosome. There was extensive use of reporters, with very similar disruptive features, to detail the subtleties in the response to pause sequences, for example. The figures detailing the di-codon pair experiments (Figure 4) and experiments focused on a natural context (Figure 5) provided little new information and potentially could be placed in a supplemental figure.

We condensed these sections and combined the Figure 4 and Figure 5, removing many of the panels to supplementary information. We re-wrote this section to make two main points. First, we found that Mbf1 and Asc1 act on the same sequences for both codon pairs and no-go decay. This observation supports the idea that their functions are strongly interconnected. Second, we identified a highly compact and efficient frameshifting site in the CGA-CGG-C sequence and found that the efficient frameshifting at this sequence is observed in other contexts (that happen to occur in native genes).

> The most critical set of experiments that brought all the ideas in the manuscript together was Figure 6, where depletion and over-expression of tRNAs and mass spec were used to determine that the frameshifting is triggered only when CGA is in the P site with its associated I:A wobble base pairing.
>
> In addition to some concerns that molecular mechanism was lacking, the reviewers all had concerns about the relative lack of analysis and discussion of the role of mRNA decay in the events being studied. As you will read in the detailed comments, the reviewers felt it is critical to generate RNA quantitation data on both the GFP and RFP mRNAs, and then to present the data in terms of these measurements. It is clear that there are some substantial effects on mRNAs levels that result from the various genetic mutations, and it likely that these effects do not account for the observed increases in GFP only on the +1 constructs. To support the strength of this conclusion, the RNA levels should be quantitated both for the (CGA)4 constructs as well as the (CGA)4+1 constructs, as the RNA changes will likely be equivalent, and there will only be increases in GFP on the +1 constructs. While we are relatively confident that the conclusions will hold, given the extent to which translation and decay are coupled in these pathways, this analysis seems critical, and a careful discussion important for the reader.

We have done this, as detailed below. The analysis using protein/ mRNA levels yields the same main conclusions (as that using protein levels), but these conclusions are more convincing (and easier to justify) with the RNA analysis. In Figure 2B and Figure 3A, we present GFP/RFP protein (fluorescence), mRNA and protein/mRNA panels for strains with mutations in MBF1, ASC1, and RPS3 (as well as wild type and relevant double mutants).

Neither the *mbf1* nor the *RPS3-K108E* mutants have substantial effects on mRNA from in-frame or +1 frame reporters, while deletion of ASC1 does affect mRNA levels (as reported previously). The *asc1* mutant exhibits a 20.8-fold increase in frameshifted protein/mRNA, compared to a 1.1-fold increase in the in-frame protein /mRNA. Thus, the *asc1* mutant clearly affects frameshifting. The protein/mRNA analysis is a far superior method to evaluate the relationships between mutants. For both the *asc1Δ mbf1Δ* double mutant and the *RPS3-K108E mbf1Δ* double mutant the increase in frameshifting is small compared to that in the *mbf1Δ* mutant (1.2 and 1.1-fold). This is a strong argument that these components act in one pathway.

We used RT-qPCR and methods of quantification described by reviewer 1 to obtain these measurements.

> In addition to this main criticism (related to measuring RNA levels carefully), there are some smaller points to be addressed in the reviewer comments. For example, the data and discussion on Hel2/Slh1 seemed over-interpreted or unclear. At a glance, there are no substantial differences that result when these factors are deleted.

We address these below.

> Moreover, the discussion of how these pathways might intersect or what these data might mean were not easy to follow.

We have re-written the Discussion section on this point and added Figure 6A to clarify the relationship.

> The manuscript would benefit from removal from the main text of figures that add little to our understanding of the role of these new factors (Mbf1 and S3) but simply support the results of the initial screen (yeast growth plates and the very detailed study in Figure 5, for example).

We have done this. We moved several panels to supplementary material: the spot test (panel E) from Figure 2; the complete analysis of frameshifting at CGA-CCG, CGA-AUA (Panels C and D) from Figure 4; the identification of the first CGA-CGG codon pair as the source of high efficiency frameshifting and the complete analysis of frameshifting at CGA-CGG (Panels A, B, D) from Figure 5.

We also removed several panels from the manuscript entirely: the analysis of *hel2* and *slh1* effects on frameshifting, and a small analysis of mRNA levels (panels C and D) from Figure 3. The complete mRNA measurements supersede the isolated measurement in Figure 3D. We removed tables from Figure 3, Figure 4 and Figure 5.

> What would benefit from more discussion is a more complete analysis about how these results fit in with the literature on mRNA decay, and most importantly, some thoughts about what Mbf1 might be doing. A model figure with the relative positions of S3 and Asc1 on the ribosome might help frame such a discussion, even in the absence of new biochemical information on Mbf1.

We have completely rewritten the Discussion section to include and clarify these points. The second and third paragraphs of the Discussion section address the intersection of the Asc1 and Mbf1 pathways and the potential role of mRNA, including information from the literature on decay. In the fourth and fifth paragraphs, we address potential molecular mechanisms by which Mbf1 may act and have added a figure to illustrate two hypothesis.

> Reviewer \#1:
>
> \[...\] The identification of the Mbf1/Rsp3 system of translational frame maintenance is an important contribution to the field and opens up new areas of research. Furthermore, this work represents a systematic genetic dissection of the determinants of translational frameshifting, and the authors confirm the conclusions informed by synthetic stalling sequences using endogenous genomically-encoded sequences. However, additional and critical controls are necessary to support the authors\' conclusions. Specifically, this work relies heavily on a ratiometric, fluorescent reporter system based on a bidirectional pGAL1,10 promoter. In this reporter, two separate mRNAs are created, one to use as an expression control (RFP) and one as an experimental condition that encodes various test sequences upstream of a GFP in different frames. By comparing protein expression levels between the two messages, the authors hope to quantify the effect of the experimental conditions on translation. Yet this system also is sensitive to changes that affect mRNA levels of sequences that stall ribosomes. In fact, all the results reported in this study could be the result of how Asc1, Mbf1, and Rps3 affect decay of mRNAs that encode stalls and frameshifts. This is more than a hypothetical possibility, as asc1∆ has been reported to affect mRNA levels of messages with stalls (Kuroha et al., 2010; Ikeuchi et al., 2016; Sitron et al., 2017).

Changes in GFP and RFP protein could indeed be due to changes in RNA levels. Thus, we measured GFP and RFP mRNA levels for (CGA) reporters (in-frame and out-of-frame) in the wild type strain as well as in *mbf1, RPS3, asc1*, and double mutants. The specific information is detailed below in response to individual comments.

The results reported in Figure 2B and Figure 3A were done by measuring GFP and RFP fluorescence and mRNA levels in triplicate in a single experiment. We also measured GFP and RFP fluorescence and mRNA levels in triplicate for the in frame optimal codon reporter (AGA) in Figure 2B in the wild type strain as well as in *mbf1, RPS3*, and double mutant. Similarly, we measured protein and mRNA simultaneously for the results reported in Figure 3A. As we described above, mutations in *mbf1* and *RPS3* do not significantly affect mRNA levels of in-frame or +1 reporters, while mutation of ASC1 has the expected effects on both in-frame and +1 frame mRNA levels. However, the 55-fold increase in frameshifted GFP/RFP in the *asc1* mutant (relative to wild type) is not accounted for by the 2.7-fold increase in mRNA; the increase in protein/mRNA of frameshifted GFP/RFP is 20-fold, while that of in-frame GFP/RFP is only 1.1-fold.

> 1\) The pGAL1,10-RFP/insert-GFP reporter system needs additional validation to ensure that measurements of GFP/RFP values truly report on increases in the frequency of stall readthrough or frameshifting rather than mRNA metabolism. This validation is of particular concern due to the data presented in Figure 3D. We plotted the mRNA levels of the (CGA-CGA)3+1 reporter against the corresponding GFP/RFP fluorescence values and found there is an almost perfect linear relationship between the levels of GFP mRNA and GFP/RFP fluorescence in the wt, asc1∆, mbf1∆, and asc1∆mbf1∆ strains. The slope we plotted is not 1, however, since we do not have the standard curves for these primer sets, we cannot know the absolute differences in mRNA, only the relative increase. Thus, the increase in GFP/RFP fluorescence in the mutant strains could be driven primarily by an increase in mRNA levels of the stalling transcript rather than increased frameshifting frequency.
>
> To validate the reporters used in the context of frameshifting and stalling, the authors must measure GFP and RFP mRNA levels of (CGA-CGA)3, (CGA-CGA)3+1, (CGA-CGA)3-1 reporters using absolute quantification (not relative quantification) in wt, asc1∆, mbf1∆, and asc1∆mbf1∆ strains by RT-qPCR.

We have done this. We used the absolute standard curve method described below to quantify these mRNAs. We cloned GFP and RFP sequences into plasmid pSP73, transcribed restriction cut plasmids with T7 RNA polymerase, digested DNA and removed small molecules in a spin column (using the RiboMAX Large Scale RNA Production System-T7 from Promega).

> \- Include a standard curve for each primer set (varying cDNA input) to map experimental conditions back to absolute input levels. Ensure the assay is conducted in the linear range of the qPCR.

We generated standard curves with each primer set using in vitro transcripts of a cloned GFP and RFP regions. We demonstrated that the in vitro transcribed RNA was intact and a single species. Each set of RT-qPCR reactions contained the 5 point standard curves and all measured values fell within the linear range.

> \- Include a plot of absolute levels of GFP mRNA vs RFP mRNA in each genetic condition to ensure that the mutations don\'t differentially affect the RFP and GFP-containing transcripts.

We have included plots of GFP mRNA vs RFP mRNA for in-frame and out-of-frame reporters in each genetic background in Figure 2---figure supplement 1A and in Figure 3---figure supplement 1C.

> \- Plot absolute GFP/RFP mRNA vs GFP/RFP fluorescence for each reporter and genetic background mentioned above to ensure that mRNA levels alone do not account for apparent changes in GFP/RFP fluorescence ratios.

We have plotted GFP/RFP fluorescence versus GFP/RFP mRNA in Figure 2---figure supplement 1B and in Figure 3---figure supplement 1D. We have also reported GFP/RFP fluorescence normalized by GFP/RFP mRNA in Figure 2B and 3A. There are only small differences in mRNA levels for *RPS3* and *mbf1* mutants in Figure 2. By contrast, mutation of ASC1 does affect mRNA levels. As shown in Figure 3---figure supplement 1D, the changes in mRNA levels correlate with in-frame expression of GFP/RFP, and with the increase in frameshifted GFP/RFP in the *asc1Δ mbf1Δ*, compared to the *mbf1Δ* strain. However, this same analysis indicates that the increase in mRNA in the *asc1* mutant relative to the wild type does not correlate with the increase in frameshifted GFP/RFP.

> Absolute quantification is described in this link: https://www.thermofisher.com/us/en/home/life-science/pcr/real-time-pcr/real-time-pcr-learning-center/real-time-pcr-basics/absolute-vs-relative-quantification-real-time-pcr.html)

We thank the reviewer. This methodology helped us.

> Reviewer \#2:
>
> \[...\] The function of Mbf1 is unclear. This protein has been implicated in both transcription and translation. As the assay for frameshifting involves a dual GFP-RFP reporter in which GFP and RFP are transcribed from the divergent GAL1,10 promoter, an important control is to examine RFP and GFP mRNA levels in the WT and mutant strains. While perhaps it is unlikely that the mbf1 mutant would differentially affect transcription of the GFP and RFP reporters, analysis of these mRNA levels for the in-frame and +1 frameshift reporters would more definitively rule out this possibility.

We did this as explained above.

> Reviewer \#3:
>
> \[...\] 1) The paper would benefit from a model that could explain Mbf1\'s function. Do the authors propose a model whereby Mbf1 binding to the mRNA prevent it from slippage? Or is it its ribosome binding that prevent the ribosome from frameshifting? I understand testing either model is beyond the scope of the current paper, but it would be nice to see how the authors are thinking about the mechanism of Mbf1.

We appreciate the reviewer's suggestion. In fact, we proposed two models, both of which depend upon the interaction of Mbf1 with both mRNA and the ribosome (RPS3). The first posits that this interaction occurs between Mbf1 and the leading ribosome, while the second posits that Mbf1 interacts with colliding ribosomes (perhaps interacting with both Rps3 and Asc1). These models are presented in Figure 6B and are discussed in the Discussion section.

New Text:

"There are two reasonable models to account for the role of Mbf1 and Rps3 in reading frame maintenance (Figure 6B). The first model is that Mbf1 has a loose association with mRNA and is recruited to the leading stalled ribosome by an interaction with Rps3; the interactions with the ribosome and the mRNA at the stall site could restrict mRNA movement in the ribosome. Based on structures of prokaryotic ribosomes caught in translocation, mRNA flexibility may occur in ribosomes lacking an A site tRNA due to few contacts with the region of mRNA near the A site (Zhou et al., 2013), or due to a failure of two rRNA pawls that lock the mRNA in a translocating ribosome (Zhou et al., 2013), or due to defects in the interactions with elongation factor 2 (Zhou et al., 2014). The ribosome stall might allow sufficient time or altered structure that one of these occurs. The second model, which is based on the observation that ribosome collisions trigger no-go decay (Simms et al., 2017b), is that Mbf1 is recruited to colliding ribosomes to buffer the collision effects; in this case Asc1 and Rps3 might both participate in Mbf1 recruitment. Mbf1 could prevent ribosome collision-mediated movement of the leading ribosome on the mRNA."

> 2\) Although unnecessary, it would be nice if the authors analyzed the ribosome profiling data of the Gilbert group on asc1 deletion to see if frameshifting occurs on the native targets that are mentioned in Figure 5---figure supplement 1 B.

Gilbert's lab generously supplied us with all the ribosome reads mapped to the genome. We attempted to examine frameshifting by generating a histogram of ribosome reads for each nucleotide in the AYT1 gene (in the *asc1* mutant). However, there were very few ribosome footprints downstream or around the CGA-CGG region in the AYT1 gene.

> Reviewer \#4:
>
> \[...\] Specific points:
>
> Not clear it is necessary to show plates and GFP reporter data in parallel throughout; results are simplest to digest in bar graphs from reporters (especially if both results are effectively the same).

We have moved the spot test data (Figure 2E) to the supplement.

> Figure 3C -- discussion of results with Hel2/Slh1 was confusing -- my look at the data says there is nothing interesting going on with these double mutants (even if the asterisks say otherwise).

The reviewer is correct; we removed the analysis of *Hel2* and *Slh1* entirely.

> Figure 3D -- mRNA levels clearly do vary -- these values should be rigorously determined for CGA-4 and CGA-4-+1 reporters -- the expectation is that mRNA level changes in various genetic backgrounds will be similar, but that protein output will be quite distinct -- these data should be presented in a scatter plot that allows correlations in mRNA and protein levels to be directly compared.

We have done this and have presented protein per mRNA levels in Figure 2B and 3A.

> Figure 4 -- revisiting of di-codon pairs does not add much to what the authors learn in this study -- the same pairs that were problematic in Cell paper appear to be problematic still, and are where the +1 FS signal is seen -- supplemental?

We examined frameshifting at the 12 most inhibitory codon pairs to find out if Mbf1 and Asc1 acted on the same sequences. We think this analysis provided evidence that Asc1 and Mbf1 generally act together. We found that very efficient frameshifting only occurred at three pairs, and these were the same three pairs at which the deletion of ASC1 suppressed the expression defect. We did remove the complete analysis of both in-frame and frameshifting in all strains to the supplement, since it did not add conceptually to the manuscript.

> Figure 5 -- huge amount of work to define some vague contextual contributions to the +1FS phenomenon -- doesn\'t add much in terms of mechanism or even the rules for context -- supplemental?

The purpose of this analysis was to identify an efficient and localized frameshifting site. To streamline the manuscript, we moved the material from Figure 5A and 5B to the supplement. We also summarized the result from these figures in a single sentence. Subsection "Mbf1 and Asc1 work at a common subset of inhibitory codon pairs and at a single 304 inhibitory codon pair in a context-dependent manner": "To define the source of efficient frameshifting in the CGA-CGG reporter, which has 3 CGA-CGG pairs (Figure 4A), we initially determined that the first CGA-CGG codon pair was responsible for highly efficient frameshifting (Figure 4D, Figure 4---figure supplement 2A and B)."

The section on native sequences is also shortened.

> Figure 6 -- very nice set of data identifying CGA in P site as the critical feature for permitting the +1 FS (or stabilization of mRNA).

Thank you.
